The case for treating tobacco dependence as a chronic disease

Michael B. Steinberg, Amy C. Schmelzer, Donna L. Richardson, Jonathan Foulds

Research output: Contribution to journalReview article

58 Citations (Scopus)

Abstract

Smoking remains the leading cause of preventable death in the United States, yet it is still regarded by many as merely a bad habit. Most smokers want to quit but find it difficult. Behavioral counseling and pharmacotherapies are available, safe, and effective in the treatment of tobacco dependence. Nicotine replacement therapy effectively delivers nicotine in safer doses without exposure to the toxins and chemicals in cigarette smoke. The optimal duration of tobacco dependence treatment is unknown, and some smokers may require extended courses. For smokers using long-term cessation medications, health care providers should encourage treatment and insurance carriers should cover it. Both tobacco dependence and such conditions as diabetes are similar in their potential to exacerbate other diseases, their behavioral components of treatment, and their effectiveness of medications. Despite these similarities, treatments for diabetes are well covered by insurance, whereas tobacco dependence treatments are often limited. Tobacco dependence should share the status of other chronic illnesses, with effective treatments given as long as is necessary to achieve successful clinical outcomes.

Original languageEnglish (US)
Pages (from-to)554-556
Number of pages3
JournalAnnals of internal medicine
Volume148
Issue number7
DOIs
StatePublished - Apr 1 2008

Fingerprint

Tobacco Use Disorder
Chronic Disease
Nicotine
Therapeutics
Insurance Carriers
Insurance
Smoke
Tobacco Products
Health Personnel
Habits
Counseling
Cause of Death
Smoking
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

Steinberg, Michael B. ; Schmelzer, Amy C. ; Richardson, Donna L. ; Foulds, Jonathan. / The case for treating tobacco dependence as a chronic disease. In: Annals of internal medicine. 2008 ; Vol. 148, No. 7. pp. 554-556.
@article{1d104d80df9c4ca7aeaf25e9b6cf4cb2,
title = "The case for treating tobacco dependence as a chronic disease",
abstract = "Smoking remains the leading cause of preventable death in the United States, yet it is still regarded by many as merely a bad habit. Most smokers want to quit but find it difficult. Behavioral counseling and pharmacotherapies are available, safe, and effective in the treatment of tobacco dependence. Nicotine replacement therapy effectively delivers nicotine in safer doses without exposure to the toxins and chemicals in cigarette smoke. The optimal duration of tobacco dependence treatment is unknown, and some smokers may require extended courses. For smokers using long-term cessation medications, health care providers should encourage treatment and insurance carriers should cover it. Both tobacco dependence and such conditions as diabetes are similar in their potential to exacerbate other diseases, their behavioral components of treatment, and their effectiveness of medications. Despite these similarities, treatments for diabetes are well covered by insurance, whereas tobacco dependence treatments are often limited. Tobacco dependence should share the status of other chronic illnesses, with effective treatments given as long as is necessary to achieve successful clinical outcomes.",
author = "Steinberg, {Michael B.} and Schmelzer, {Amy C.} and Richardson, {Donna L.} and Jonathan Foulds",
year = "2008",
month = "4",
day = "1",
doi = "10.7326/0003-4819-148-7-200804010-00012",
language = "English (US)",
volume = "148",
pages = "554--556",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "7",

}

The case for treating tobacco dependence as a chronic disease. / Steinberg, Michael B.; Schmelzer, Amy C.; Richardson, Donna L.; Foulds, Jonathan.

In: Annals of internal medicine, Vol. 148, No. 7, 01.04.2008, p. 554-556.

Research output: Contribution to journalReview article

TY - JOUR

T1 - The case for treating tobacco dependence as a chronic disease

AU - Steinberg, Michael B.

AU - Schmelzer, Amy C.

AU - Richardson, Donna L.

AU - Foulds, Jonathan

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Smoking remains the leading cause of preventable death in the United States, yet it is still regarded by many as merely a bad habit. Most smokers want to quit but find it difficult. Behavioral counseling and pharmacotherapies are available, safe, and effective in the treatment of tobacco dependence. Nicotine replacement therapy effectively delivers nicotine in safer doses without exposure to the toxins and chemicals in cigarette smoke. The optimal duration of tobacco dependence treatment is unknown, and some smokers may require extended courses. For smokers using long-term cessation medications, health care providers should encourage treatment and insurance carriers should cover it. Both tobacco dependence and such conditions as diabetes are similar in their potential to exacerbate other diseases, their behavioral components of treatment, and their effectiveness of medications. Despite these similarities, treatments for diabetes are well covered by insurance, whereas tobacco dependence treatments are often limited. Tobacco dependence should share the status of other chronic illnesses, with effective treatments given as long as is necessary to achieve successful clinical outcomes.

AB - Smoking remains the leading cause of preventable death in the United States, yet it is still regarded by many as merely a bad habit. Most smokers want to quit but find it difficult. Behavioral counseling and pharmacotherapies are available, safe, and effective in the treatment of tobacco dependence. Nicotine replacement therapy effectively delivers nicotine in safer doses without exposure to the toxins and chemicals in cigarette smoke. The optimal duration of tobacco dependence treatment is unknown, and some smokers may require extended courses. For smokers using long-term cessation medications, health care providers should encourage treatment and insurance carriers should cover it. Both tobacco dependence and such conditions as diabetes are similar in their potential to exacerbate other diseases, their behavioral components of treatment, and their effectiveness of medications. Despite these similarities, treatments for diabetes are well covered by insurance, whereas tobacco dependence treatments are often limited. Tobacco dependence should share the status of other chronic illnesses, with effective treatments given as long as is necessary to achieve successful clinical outcomes.

UR - http://www.scopus.com/inward/record.url?scp=42249113683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42249113683&partnerID=8YFLogxK

U2 - 10.7326/0003-4819-148-7-200804010-00012

DO - 10.7326/0003-4819-148-7-200804010-00012

M3 - Review article

VL - 148

SP - 554

EP - 556

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 7

ER -